Benign Prostatic Hyperplasia Treatment Market (Treatment: Drug Class, Minimally Invasive Surgeries, Laser Therapy, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Report Highlights
Benign Prostatic Hyperplasia Treatment Market – Scope of Report
TMR’s report on the global benign prostatic hyperplasia treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global benign prostatic hyperplasia treatment market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global benign prostatic hyperplasia treatment market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the benign prostatic hyperplasia treatment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global benign prostatic hyperplasia treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global benign prostatic hyperplasia treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global benign prostatic hyperplasia treatment market.
The report delves into the competitive landscape of the global benign prostatic hyperplasia treatment market. Key players operating in the global benign prostatic hyperplasia treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global benign prostatic hyperplasia treatment market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market benign prostatic hyperplasia treatment.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
- Company websites, presentations, annual reports, white papers, technical paper, product brochure
- Internal and external proprietary databases and relevant patents
- National government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
- Industry Sources:
- WorldWideScience.org
- Elsevier, Inc.
- National Institutes of Health (NIH)
- PubMed
- NCBI
- Department of Health Care Service
- Trade Data Sources
- Trade Map
- UN Comtrade
- Trade Atlas
- Company Information
- OneSource Business Browser
- Hoover’s
- Factiva
- Bloomberg
- Mergers & Acquisitions
- Thomson Mergers & Acquisitions
- MergerStat
- Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
- Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
- Helps in validating and strengthening secondary research findings
- Further develops the analysis team’s expertise and market understanding
- Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
- Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
- Purchasing/Sourcing managers, technical personnel, distributors
- Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
- Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
- Advanced Oncotherapy PLC
- Danfysik A/S
- Hitachi, Ltd.
- IBA Worldwide
- Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
- Table 1 : Global Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Treatment 2017–2031
- Table 2 : Global Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Drug Class 2017–2031
- Table 3 : Global Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Minimally Invasive Surgeries2017–2031
- Table 4 : Global Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
- Table 5 : Global Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
- Table 6 : North America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
- Table 7 : North America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Treatment 2017–2031
- Table 8 : North America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Drug Class 2017–2031
- Table 9 : North America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Minimally Invasive Surgeries2017–2031
- Table 10 : North America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
- Table 11 : North America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
- Table 12 : Europe Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
- Table 13 : Europe Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Treatment 2017–2031
- Table 14 : Europe Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Drug Class 2017–2031
- Table 15 : Europe Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Minimally Invasive Surgeries2017–2031
- Table 16 : Europe Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
- Table 17 : Europe Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
- Table 18 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
- Table 19 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Treatment 2017–2031
- Table 20 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Drug Class 2017–2031
- Table 21 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Minimally Invasive Surgeries, 2017–2031
- Table 22 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
- Table 23 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
- Table 24 : Latin America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
- Table 25 : Latin America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Treatment 2017–2031
- Table 26 : Latin America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Drug Class 2017–2031
- Table 27 : Latin America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Minimally Invasive Surgeries2017–2031
- Table 28 : Latin America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
- Table 29 : Latin America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
- Table 30 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
- Table 31 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Treatment 2017–2031
- Table 32 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Drug Class 2017–2031
- Table 33 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Minimally Invasive Surgeries2017–2031
- Table 34 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
- Table 35 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
- Figure 1 : Global Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, 2017–2031
- Figure 2 : Global Benign Prostatic Hyperplasia Treatment Market Value Share, by Treatment, 2021
- Figure 3 : Global Benign Prostatic Hyperplasia Treatment Market Value Share, by End-user, 2021
- Figure 4 : Global Benign Prostatic Hyperplasia Treatment Market, by Treatment, 2021 and 2031
- Figure 5 : Global Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
- Figure 6 : Global Benign Prostatic Hyperplasia Treatment Market, by Drug Class, 2021–2031
- Figure 7 : Global Benign Prostatic Hyperplasia Treatment Market, by Minimally Invasive Surgeries, 2021–2031
- Figure 8 : Global Benign Prostatic Hyperplasia Treatment Market, by Laser Therapy, 2021–2031
- Figure 9 : Global Benign Prostatic Hyperplasia Treatment Market, by Others, 2021–2031
- Figure 10 : Global Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Drug Class, 2021–2031
- Figure 11 : Global Benign Prostatic Hyperplasia Treatment Market, by End-user, 2021 and 2031
- Figure 12 : Global Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by End-user, 2021–2031
- Figure 13 : Global Benign Prostatic Hyperplasia Treatment Market (US$ Mn), by Hospitals, 2017–2031
- Figure 14 : Global Benign Prostatic Hyperplasia Treatment Market (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
- Figure 15 : Global Benign Prostatic Hyperplasia Treatment Market (US$ Mn), by Specialty Clinics, 2017–2031
- Figure 16 : Global Benign Prostatic Hyperplasia Treatment Market (US$ Mn), by Others, 2017–2031
- Figure 17 : Global Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Region, 2021 and 2031
- Figure 18 : Global Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Region, 2017–2031
- Figure 19 : North America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, 2017–2031
- Figure 20 : North America Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Country, 2021 and 2031
- Figure 21 : North America Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
- Figure 22 : North America Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
- Figure 23 : North America Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
- Figure 24 : North America Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 25 : North America Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by End-user, 2021–2031
- Figure 26 : Europe Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, 2017–2031
- Figure 27 : Europe Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
- Figure 28 : Europe Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
- Figure 29 : Europe Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
- Figure 30 : Europe Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
- Figure 31 : Europe Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 32 : Europe Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by End-user, 2021–2031
- Figure 33 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, 2017–2031
- Figure 34 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
- Figure 35 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
- Figure 36 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
- Figure 37 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
- Figure 38 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 39 : Asia Pacific Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by End-user, 2021–2031
- Figure 40 : Latin America Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, 2017–2031
- Figure 41 : Latin America Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
- Figure 42 : Latin America Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
- Figure 43 : Latin America Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
- Figure 44 : Latin America Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
- Figure 45 : Latin America Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 46 : Latin America Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by End-user, 2021–2031
- Figure 47 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value (US$ Mn) Forecast, 2017–2031
- Figure 48 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
- Figure 49 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
- Figure 50 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
- Figure 51 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by Treatment, 2021–2031
- Figure 52 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 53 : Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Attractiveness Analysis, by End-user, 2021–2031
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.
Similar Reports from Transparency
Benign Prostatic Hyperplasia Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027
Benign Prostatic Hyperplasia Treatment Market - Scope of the Study
Transparency Market Research (TMR), in its recently published research report, quantifies the growth of the benign prostatic hyperplasia treatment market during the forecast period of 2019-2027. This exclusive research report on the global benign prostatic hyperplasia treatment market offers a detailed overview of the benign prostatic hyperplasia treatment market, ...